AU659172B2 - Carbapenem derivative - Google Patents

Carbapenem derivative Download PDF

Info

Publication number
AU659172B2
AU659172B2 AU20002/92A AU2000292A AU659172B2 AU 659172 B2 AU659172 B2 AU 659172B2 AU 20002/92 A AU20002/92 A AU 20002/92A AU 2000292 A AU2000292 A AU 2000292A AU 659172 B2 AU659172 B2 AU 659172B2
Authority
AU
Australia
Prior art keywords
lower alkyl
group
alkyl group
compound
hydrogen atom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU20002/92A
Other languages
English (en)
Other versions
AU2000292A (en
Inventor
Takeshi Hayano
Yohhei Ishida
Hiroko Koda
Toshiyuki Nishi
Kazuyuki Sugita
Makoto Takemura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Pharmaceutical Co Ltd
Original Assignee
Daiichi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Pharmaceutical Co Ltd filed Critical Daiichi Pharmaceutical Co Ltd
Publication of AU2000292A publication Critical patent/AU2000292A/en
Application granted granted Critical
Publication of AU659172B2 publication Critical patent/AU659172B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU20002/92A 1991-06-20 1992-06-19 Carbapenem derivative Ceased AU659172B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP14846991 1991-06-20
JP3105492 1992-02-18
JP3-148469 1992-02-18
JP4-31054 1992-02-18
PCT/JP1992/000790 WO1993000344A1 (en) 1991-06-20 1992-06-19 Carbapenem derivative

Publications (2)

Publication Number Publication Date
AU2000292A AU2000292A (en) 1993-01-25
AU659172B2 true AU659172B2 (en) 1995-05-11

Family

ID=26369502

Family Applications (1)

Application Number Title Priority Date Filing Date
AU20002/92A Ceased AU659172B2 (en) 1991-06-20 1992-06-19 Carbapenem derivative

Country Status (15)

Country Link
US (1) US5559224A (https=)
EP (1) EP0641795B9 (https=)
JP (1) JP3048196B2 (https=)
KR (1) KR100189667B1 (https=)
AT (1) ATE224897T1 (https=)
AU (1) AU659172B2 (https=)
CA (1) CA2111974C (https=)
DE (1) DE69232791T2 (https=)
DK (1) DK0641795T3 (https=)
ES (1) ES2184731T3 (https=)
FI (1) FI101537B (https=)
NO (1) NO303636B1 (https=)
RU (1) RU2091381C1 (https=)
TW (1) TW201747B (https=)
WO (1) WO1993000344A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2026424A6 (es) * 1991-02-26 1992-04-16 Play Sa Cuna infantil plegable.
EP0882728B1 (en) * 1995-12-21 2002-09-04 Sankyo Company Limited 1-methylcarbapenem derivatives
PL343728A1 (en) * 1998-05-01 2001-09-10 Kyoto Pharmaceutical Ind Carbapenem derivatives, utilization thereof and intermediate compounds of the same
AU2001230550A1 (en) * 2000-01-31 2001-08-14 Sankyo Company Limited 1-methylcarbapenem compounds
IN191798B (https=) 2000-11-03 2004-01-03 Ranbaxy Lab Ltd
CN1511156A (zh) * 2001-05-21 2004-07-07 ����ҩƷ��ҵ��ʽ���� 碳青霉烯化合物
WO2003027067A2 (en) * 2001-09-26 2003-04-03 Merck & Co., Inc. Process for making carbapenem compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1283906C (en) * 1983-05-09 1991-05-07 Makoto Sunagawa .beta.-LACTAM COMPOUNDS AND PRODUCTION THEREOF
JPS6019787A (ja) * 1983-07-12 1985-01-31 Sumitomo Chem Co Ltd 新規なβ−ラクタム化合物及びその製造法
JPS60233076A (ja) * 1984-05-03 1985-11-19 Sumitomo Chem Co Ltd 新規なβ−ラクタム化合物およびその製造法
KR880006244A (ko) * 1986-11-24 1988-07-22 후지사와 도모 기찌 로 3-피롤리디닐티오-1-아자바이스클로[3.2.0]햅트2-엔-2-카르복실산 화합물 및 이의 제조방법
AU631671B2 (en) * 1989-08-04 1992-12-03 Banyu Pharmaceutical Co., Ltd. 2-(2-vinylpyrrolidinylthio)carbapenem derivatives

Also Published As

Publication number Publication date
DK0641795T3 (da) 2003-01-20
AU2000292A (en) 1993-01-25
ATE224897T1 (de) 2002-10-15
KR940701395A (ko) 1994-05-28
NO934670L (no) 1994-02-18
RU2091381C1 (ru) 1997-09-27
ES2184731T3 (es) 2003-04-16
FI935698A0 (fi) 1993-12-17
CA2111974A1 (en) 1993-01-07
EP0641795B9 (en) 2003-01-29
CA2111974C (en) 2001-07-24
WO1993000344A1 (en) 1993-01-07
KR100189667B1 (ko) 1999-06-01
EP0641795A1 (en) 1995-03-08
DE69232791T2 (de) 2003-05-15
FI935698A7 (fi) 1994-02-04
FI101537B1 (fi) 1998-07-15
NO303636B1 (no) 1998-08-10
TW201747B (https=) 1993-03-11
JP3048196B2 (ja) 2000-06-05
EP0641795A4 (en) 1994-06-09
US5559224A (en) 1996-09-24
FI101537B (fi) 1998-07-15
JPH05294969A (ja) 1993-11-09
EP0641795B1 (en) 2002-09-25
NO934670D0 (no) 1993-12-17
DE69232791D1 (en) 2002-10-31

Similar Documents

Publication Publication Date Title
EP0126587B1 (en) Carboxylic thio-pyrrolidinyl beta-lactam compounds and production thereof
IE47958B1 (en) 3-substituted-6-substituted-7-oxo-1-azabicyclo(3.2.0)-hept-2-ene-2-carboxylic acid,its preparation and pharamaceutical compositions containing it
IE58098B1 (en) 7-Substituted-1-cyclopropyl-6,8-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids; 7-substituted-1-cyclopropyl-1,4-dihydro-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acids; their derivatives; and a process for preparing the compounds
AU659172B2 (en) Carbapenem derivative
AU662972B2 (en) Carbapenem derivatives as antibiotics and intermediates thereof
CA1284500C (en) Carbapenem antibiotics
EP0443498A1 (en) Isoindoline derivatives
CA1272719A (en) Carbapenem antibiotics
EP0411636B1 (en) Piperidylthiocarbapenem derivatives
JPH0463076B2 (https=)
JP3411589B2 (ja) カルバペネム誘導体
EP0406863B1 (en) Cyclic amidinylthiocarbapenem derivatives
JPH0436282A (ja) カルバペネム誘導体
JP3242677B2 (ja) 新規なβ−ラクタム化合物及びその製造法
JPWO1993000344A1 (ja) カルバペネム誘導体
JP3037827B2 (ja) カルバペネム誘導体
US4361512A (en) 2-Substituted thio-6-substituted-carbapen-2-em-3-carboxylic acids
JPH0616671A (ja) カルバペネム誘導体の製造方法
JPS59205379A (ja) 新規なβ−ラクタム化合物及びその製造法
PT946497E (pt) Processo para a preparacao de antagonistas de nmda
PT85432B (pt) Processo para a preparacao de um composto carbapenemico sob a forma cristalina e de composicoes farmaceuticas que o contem
JPWO1998034936A1 (ja) カルバペネム化合物、その用途およびその中間体化合物
JPS60222487A (ja) ペネム誘導体
JPWO1991000864A1 (ja) カルバペネム誘導体

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired